More patients reach glycaemic control with a fixed‐ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc t...

por Frias, Juan, Puig Domingo, Manuel, Meneghini, Luigi, Napoli, Raffaele, Liu, Minzhi, Soltes Rak, Erika, Aroda, Vanita R.
Publicado 2018